Already a Bloomberg.com user?
Sign in with the same account.
Don't have an account?
Help! I can't access my account.
April 24 (Bloomberg) -- Bloomberg's Jonathan Ferro reports that low patent expirations may clear the obstacles to growth for pharma stocks. He speaks on Bloomberg Television's "Countdown." (Source: Bloomberg)
On Air Now
Taking Stock with Pimm Fox
©2014 Bloomberg L.P. All Rights Reserved. Made in NYC